Lexeo Therapeutics, Inc. Announces Q2 2026 Financial Results

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) issued a press release announcing its business highlights and financial results for the three and six months ended June 30, 2026.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai